By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enterome, a privately held biomarker development firm, has raised €5 million ($6.6 million) in a series A round of private funding, it said Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.